Ralf Huss, MD, PhD
Ralf Huss, MD, PhD, Adjunct Professor
Ralf Huss is currently Adjunct Professor at the Institute for Regenrative Medicine, as well as Professor, Managing Director and Chief Scientific Officer at Apceth - Applied Cell Technology. He also holds a position as Chief Medical Officer and Head of Clinical Affairs at Defeniens AG and was previously Vice President of Research at Roche Diagnostic.
Before joining Roche, Dr. Huss received his graduate and post-doctoral training in Immunology and Transplantation Medicine with the Nobel laureates Rolf Zinkernagel in Zurich and E. Donnell Thomas at the Fred Hutchinson Cancer Research Center in Seattle.
Dr. Huss is a board-certified (surgical) pathologist and holds further certifications in molecular pathology and transfusion medicine. He has co-authored more than 100 papers and reviews, mainly in the field of cancer research, stem cell biology and cell therapy. Dr. Huss is Professor of Pathology at the University of Munich and holds various academic positions in Germany and abroad.
In his various roles, Dr. Huss is strongly committed to tissue based biomarker research & development in Oncology, but also all other disease biology areas. His roles and responsibilities also includes the strengthening of any technology and diagnostic portfolio to enable Personalized HealthCare strategies including digital pathology.
Born and raised in Germany, Dr. Huss has also founded some smaller biotech companies and holds various international appointments e.g. with the European Academy of Science and the International Society of Tissue Engineering and Regenerative Medicine.